Outlook Therapeutics
OTLK

股本结构

单位：万股
公告日期 2025-12-19 2025-12-19 2025-08-14 2025-08-14 2025-05-23 2025-05-15
证券总股本 6411.44 5388.72 4441.95 4347.91 4285.37 3356.80
普通股本 6411.44 5388.72 4441.95 4347.91 4285.37 3356.80
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-12-16 2025-09-30 2025-08-11 2025-06-30 2025-05-27 2025-05-13
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-12-19 6411.44 未披露 定期报告 2025-12-16
2025-12-19 5388.72 未披露
更多>>
From September 30, 2024 to September 30, 2025 Issuance of common stock and common stock warrants in connection with exercise of common stock warrants Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
2025-09-30
2025-08-14 4441.95 未披露 定期报告 2025-08-11
2025-08-14 4347.91 未披露
更多>>
From March 31, 2025 to June 30, 2025 Sale of common stock, net of issuance costs Issuance of common stock in connection with conversion of convertible promissory note
2025-06-30
2025-05-23 4285.37 未披露
更多>>
Common stock offered 9,285,714 shares by the company
2025-05-27
2025-05-15 3356.80 未披露 定期报告 2025-05-13
2025-05-15 3290.70 未披露
更多>>
From December 31, 2024 to March 31, 2025 Sale of common stock, net of issuance costs Issuance of common stock and common stock warrants in connection with exercise of common stock warrants
2025-03-31
2025-03-20 3262.02 未披露 定期报告 2025-03-13
2025-01-23 3201.72 未披露 定期报告 2025-01-24
2025-01-23 3198.01 未披露 定期报告 2025-01-21
2025-02-14 2490.56 未披露
更多>>
From October 1, 2023 to December 31, 2024 Sale of common stock, net of issuance costs
2024-12-31
2024-12-27 2490.56 未披露 定期报告 2024-12-24
2024-12-27 2390.56 未披露
更多>>
From September 30, 2023 to September 30, 2024 Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
2024-09-30
2024-08-14 2365.56 未披露 定期报告 2024-08-12
2024-08-14 2340.56 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
2024-06-30
2024-05-15 2340.56 未披露 定期报告 2024-05-13
2024-04-26 2329.85 未披露 定期报告 2024-04-15
2024-05-15 2201.28 未披露
更多>>
From December 31, 2023 to March 31, 2024 Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
2024-03-31
2024-03-25 2158.43 未披露 定期报告 2024-03-18
2024-03-12 1300.00 未披露
更多>>
1-for-20 reverse stock split
2024-03-14
2024-03-12 26030.00 未披露 定期报告 2024-03-12
2023-12-22 26025.75 未披露
更多>>
From September 30, 2022 to September 30, 2023 Issuance of common stock upon conversion of convertible promissory accrued interest Sale of common stock, net of issuance costs
2023-09-30
2023-08-14 26024.50 未披露 定期报告 2023-08-10
2023-08-14 25870.41 未披露
更多>>
From March 31, 2023 to June 30, 2023 Sale of common stock, net of issuance costs
2023-06-30
2023-02-14 25666.68 未披露
更多>>
From October 1, 2022 to December 31, 2022 Sale of common stock, net of issuance costs
2022-12-31
2022-12-23 25666.68 未披露
更多>>
Common stock offered by the company 28,460,831 shares
2022-12-28
2022-12-29 22820.60 未披露 定期报告 2022-12-27
2022-12-29 22731.06 未披露 定期报告 2022-09-30
2022-08-10 22614.46 未披露 定期报告 2022-08-08
2022-08-10 22594.27 未披露
更多>>
From March 31, 2022 to June 30, 2022 Sale of common stock, net of issuance costs
2022-06-30
2022-05-13 22594.27 未披露 定期报告 2022-05-11
2022-05-13 22579.27 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock in connection with exercise of stock options Sale of common stock, net of issuance costs
2022-03-31
2022-02-14 22427.63 未披露 定期报告 2022-02-11
2022-02-14 22426.06 未披露
更多>>
From October 1, 2021 to December 31, 2021 Issuance of common stock in connection with exercise of stock options Sale of common stock, net of issuance costs
2021-12-31
2021-12-23 22426.06 未披露 定期报告 2021-12-20
2021-11-29 21812.36 未披露
更多>>
1.Common stock offered 40,000,000 shares. 2.The number of shares of common stock to be outstanding immediately after this offering is based on 174,813,326 shares of common stock outstanding as of June 30, 2021.
2021-11-29
2021-12-23 17646.16 未披露
更多>>
From September 30, 2020 to September 30, 2021 Issuance of common stock in connection with exercise of warrants Sale of common stock, net of issuance costs
2021-09-30
2021-08-13 17534.12 未披露 定期报告 2021-08-11
2021-08-13 17481.33 未披露
更多>>
From April 1, 2021 to June 30, 2021 Sale of common stock, net of issuance costs
2021-06-30
2021-05-14 17360.58 未披露
更多>>
From January 1, 2021 to March 31, 2021 Issuance of common stock in connection with exercise of warrants Sale of common stock, net of issuance costs
2021-03-31
2021-03-26 17360.58 未披露 定期报告 2021-02-28
2021-02-16 17343.20 未披露 定期报告 2021-02-12
2021-02-22 17241.84 未披露 定期报告 2021-02-09
2021-02-02 16518.31 未披露
更多>>
1.Common stock offered by the company 35,000,000 shares. 2.The number of shares of common stock outstanding is based on 127,183,109 shares of common stock outstanding as of September 30, 2020.
2021-02-02
2021-02-16 12718.31 未披露 定期报告 2020-12-31
2020-08-18 12718.31 未披露 定期报告 2020-08-06
2020-08-14 12636.01 未披露
更多>>
From April 1, 2020 to June 30, 2020 Issuance of common stock in connection with conversion of senior secured notes and interest Sale of common stock, net of issuance costs
2020-06-30
2020-06-24 12316.64 未披露
更多>>
1.Common stock offered by the company 8,407,411 shares 2.The number of shares of common stock outstanding is based on 113,935,910 shares of common stock outstanding as of March 31, 2020
2020-06-24
2020-05-15 9137.76 未披露 定期报告 2020-05-13
2020-05-15 8975.12 未披露
更多>>
From January 1, 2020 to March 31, 2020 Conversion of Series A-1 convertible preferred stock to common stock Issuance of common stock in connection with exercise of warrants Sale of common stock, net of issuance costs Issuance of restricted common stock to MTTR, LLC principals
2020-03-31
2020-02-14 4308.88 6.81 定期报告 2020-02-07
2020-02-14 3843.09 6.81
更多>>
From October 1, 2019 to December 31, 2019 Issuance of common stock in connection with exercise of warrants Issuance of common stock in connection with conversion of stockholder notes Issuance of vested restricted stock units Series A-1 convertible preferred stock dividends and related settlement
2019-12-31
2019-12-19 3010.32 未披露 定期报告 2019-12-16
2019-12-19 2861.00 6.65
更多>>
From September 30, 2018 to September 30, 2019 Series A-1 convertible preferred stock dividends and related settlement Issuance of common stock in connection with exercise of warrants Issuance of common stock in connection with public offering, net of costs Private placement sale of common stock, net of costs Issuance of vested restricted stock units Issuance of common stock in connection with conversion of senior secured notes Issuance of common stock in connection with conversion of stockholder notes
2019-09-30
2019-08-01 2823.35 6.48 定期报告 2019-07-25
2019-08-14 2823.30 6.48
更多>>
From April 1, 2019 to June 30, 2019 Series A-1 convertible preferred stock dividends and related settlement Proceeds from exercise of common stock warrants Private placement sale of common stock, net of costs
2019-06-30
2019-06-03 2605.08 未披露 定期报告 2019-05-31
2019-05-15 2209.96 未披露 定期报告 2019-05-13
2019-05-15 1175.96 6.33
更多>>
from January 1, 2019 to March 31, 2019 Series A-1 convertible preferred stock dividends and related settlement Proceeds from exercise of common stock warrants Private placement sale of common stock, net of costs Issuance of vested restricted stock units Issuance of common stock in connection with conversion of senior secured notes
2019-03-31
2019-03-18 1180.00 未披露
更多>>
As previously disclosed, at the Company's Annual Meeting of Stockholders held on September 21, 2018, the Company's stockholders approved a proposal authorizing the Company's Board of Directors to effect a reverse stock split by a ratio of not less than one-for-two and not more than one-for-ten.The reverse stock split will reduce the number of shares of common stock issued and outstanding from approximately 94.1 million to approximately 11.8 million. There is no change to the number of authorized shares.
2019-03-18
2019-02-14 9367.37 未披露 定期报告 2019-02-12
2019-02-14 8509.18 6.17
更多>>
from October 1, 2018 to December 31, 2018 Series A-1 convertible preferred stock dividends and related settlement Proceeds from exercise of common stock warrants Private placement sale of common stock, net of costs Issuance of vested restricted stock units
2018-12-31
2018-12-18 8509.11 未披露 定期报告 2018-12-14
2018-12-18 8079.80 6.02 定期报告 2018-11-30
2018-12-18 7222.04 6.02
更多>>
From September 30, 2017 to September 30, 2018 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Private placement sale of common stock and common stock warrants, net of costs Sale of Series A convertible preferred stock and common stock warrants, net of costs Series A convertible preferred stock dividends and related settlement Conversion of Series A convertible preferred stock into common stock Conversion of Series A convertible preferred stock into Series A-1 convertible preferred stock Series A-1 convertible preferred stock dividends and related settlement Conversion of Series B convertible preferred stock into common stock
2018-09-30
2018-08-14 7219.85 5.87 定期报告 2018-07-24
2018-08-14 7219.85 5.22
更多>>
From October 1, 2017 to June 30, 2018 Sale of Series A convertible preferred stock and common stock warrants, net of costs Series A convertible preferred stock dividends and settlement Conversion of Series A convertible preferred stock into common stock Conversion of senior secured notes into Series B convertible preferred stock Conversion of Series B convertible preferred stock into common stock Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Private placement sale of common stock and common stock warrants, net of costs
2018-06-30
2018-05-15 3233.26 未披露 定期报告 2018-05-14
2018-05-15 2574.05 176.10
更多>>
From October 1, 2017 to March 31, 2018 Sale of Series A convertible preferred stock and common stock warrants, net of costs Series A convertible preferred stock dividends and settlement Conversion of senior secured notes into Series B convertible preferred stock Issuance of vested restricted stock units
2018-03-31
2018-02-14 2574.05 未披露 定期报告 2018-02-12
2018-02-14 2553.07 175.00
更多>>
from October 1, 2017 to December 31, 2017 Sale of Series A convertible preferred stock and common stock warrants, net of costs Conversion of senior secured notes into Series B convertible preferred stock Issuance of vested restricted stock units
2017-12-31
2017-12-29 2553.07 未披露 定期报告 2017-12-27
2017-12-29 2493.39 3.26
更多>>
From September 30, 2016 To September 30, 2017 Sale of Series A convertible preferred, net of costs Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Issuance of common stock in connection with equity facility Sale of common stock, net of issuance costs
2017-09-30
2017-09-29 2493.26 3.26 定期报告 2017-09-18
2017-08-14 2467.64 未披露 定期报告 2017-08-11
2017-08-14 2465.91 未披露
更多>>
from October 1, 2016 to June 30, 2017 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Issuance of common stock in connection with equity facility Sale of common stock, net of issuance costs
2017-06-30
2017-05-15 2445.30 未披露 定期报告 2017-05-11
2017-05-15 2410.00 未披露
更多>>
from October 1, 2016 to March 31, 2017 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Issuance of common stock in connection with equity facility Sale of common stock, net of issuance costs
2017-03-31
2017-03-10 2392.33 未披露 定期报告 2017-03-08
2017-02-14 2363.14 未披露 定期报告 2017-02-10
2017-02-14 2358.80 未披露
更多>>
From October 1, 2016 to December 31, 2016 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units
2016-12-31
2016-12-29 2357.89 未披露 定期报告 2016-12-28
2016-08-15 2280.28 未披露
更多>>
from October 1, 2015 to June 30, 2016 Reincorporation to a Delaware Corporation Reclassifiation of redeemable common stock upon consummation of the initial public offering Issuance of common stock upon the dissolution of Parilis Conversion of Series A preferred stock in connection with the initial public offering Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs Sale of common stock units upon consummation of initial public offering and concurrent private placement, net of issuance costs On April 26, 2016, the Company filed a certificate of amendment to amend its certificate of incorporation effecting a 1-for-3.45 reverse split of the Company’s common stock.
2016-06-30
2016-05-13 2280.28 未披露
更多>>
1.On April 26, 2016, the Company filed a certificate of amendment to amend its certificate of incorporation effecting a 1-for-3.45 reverse split of the Company’s common stock.
2016-06-14
2016-04-27 1407.90 1.18
更多>>
from October 1, 2015 to April 27, 2016 Reincorporation to a Delaware Corporation Issuance of preferred and common stock upon the dissolution of Parilis Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs On April 26, 2016, the Company filed a certificate of amendment to amend its certificate of incorporation effecting a 1-for-3.45 reverse split of the Company’s common stock.
2016-04-27
2016-06-27 1416.63 1.18
更多>>
from October 1, 2015 to March 31, 2016 Reincorporation to a Delaware Corporation Issuance of common stock upon the dissolution of Parilis Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs
2016-03-31
2016-02-12 4857.27 1.18
更多>>
from October 1, 2015 to December 31, 2015 Reincorporation to a Delaware Corporation Issuance of preferred and common stock upon the dissolution of Parilis Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs
2015-12-31
2016-01-15 3855.53 0.76
更多>>
from September 30, 2014 to September 30, 2015 Repurchase of Series A redeemable preferred stock and deemed dividends Accretion of redeemable preferred stock, common stock and noncontrolling interests Sale of common stock, net of issuance costs
2015-09-30
From September 30, 2024 to September 30, 2025 Issuance of common stock and common stock warrants in connection with exercise of common stock warrants Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
From March 31, 2025 to June 30, 2025 Sale of common stock, net of issuance costs Issuance of common stock in connection with conversion of convertible promissory note
Common stock offered 9,285,714 shares by the company
From December 31, 2024 to March 31, 2025 Sale of common stock, net of issuance costs Issuance of common stock and common stock warrants in connection with exercise of common stock warrants
From October 1, 2023 to December 31, 2024 Sale of common stock, net of issuance costs
From September 30, 2023 to September 30, 2024 Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
From March 31, 2024 to June 30, 2024 Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
From December 31, 2023 to March 31, 2024 Issuance of common stock in connection with conversion of convertible promissory note Sale of common stock, net of issuance costs
1-for-20 reverse stock split
From September 30, 2022 to September 30, 2023 Issuance of common stock upon conversion of convertible promissory accrued interest Sale of common stock, net of issuance costs
From March 31, 2023 to June 30, 2023 Sale of common stock, net of issuance costs
From October 1, 2022 to December 31, 2022 Sale of common stock, net of issuance costs
Common stock offered by the company 28,460,831 shares
From March 31, 2022 to June 30, 2022 Sale of common stock, net of issuance costs
From December 31, 2021 to March 31, 2022 Issuance of common stock in connection with exercise of stock options Sale of common stock, net of issuance costs
From October 1, 2021 to December 31, 2021 Issuance of common stock in connection with exercise of stock options Sale of common stock, net of issuance costs
1.Common stock offered 40,000,000 shares. 2.The number of shares of common stock to be outstanding immediately after this offering is based on 174,813,326 shares of common stock outstanding as of June 30, 2021.
From September 30, 2020 to September 30, 2021 Issuance of common stock in connection with exercise of warrants Sale of common stock, net of issuance costs
From April 1, 2021 to June 30, 2021 Sale of common stock, net of issuance costs
From January 1, 2021 to March 31, 2021 Issuance of common stock in connection with exercise of warrants Sale of common stock, net of issuance costs
1.Common stock offered by the company 35,000,000 shares. 2.The number of shares of common stock outstanding is based on 127,183,109 shares of common stock outstanding as of September 30, 2020.
From April 1, 2020 to June 30, 2020 Issuance of common stock in connection with conversion of senior secured notes and interest Sale of common stock, net of issuance costs
1.Common stock offered by the company 8,407,411 shares 2.The number of shares of common stock outstanding is based on 113,935,910 shares of common stock outstanding as of March 31, 2020
From January 1, 2020 to March 31, 2020 Conversion of Series A-1 convertible preferred stock to common stock Issuance of common stock in connection with exercise of warrants Sale of common stock, net of issuance costs Issuance of restricted common stock to MTTR, LLC principals
From October 1, 2019 to December 31, 2019 Issuance of common stock in connection with exercise of warrants Issuance of common stock in connection with conversion of stockholder notes Issuance of vested restricted stock units Series A-1 convertible preferred stock dividends and related settlement
From September 30, 2018 to September 30, 2019 Series A-1 convertible preferred stock dividends and related settlement Issuance of common stock in connection with exercise of warrants Issuance of common stock in connection with public offering, net of costs Private placement sale of common stock, net of costs Issuance of vested restricted stock units Issuance of common stock in connection with conversion of senior secured notes Issuance of common stock in connection with conversion of stockholder notes
From April 1, 2019 to June 30, 2019 Series A-1 convertible preferred stock dividends and related settlement Proceeds from exercise of common stock warrants Private placement sale of common stock, net of costs
from January 1, 2019 to March 31, 2019 Series A-1 convertible preferred stock dividends and related settlement Proceeds from exercise of common stock warrants Private placement sale of common stock, net of costs Issuance of vested restricted stock units Issuance of common stock in connection with conversion of senior secured notes
As previously disclosed, at the Company's Annual Meeting of Stockholders held on September 21, 2018, the Company's stockholders approved a proposal authorizing the Company's Board of Directors to effect a reverse stock split by a ratio of not less than one-for-two and not more than one-for-ten.The reverse stock split will reduce the number of shares of common stock issued and outstanding from approximately 94.1 million to approximately 11.8 million. There is no change to the number of authorized shares.
from October 1, 2018 to December 31, 2018 Series A-1 convertible preferred stock dividends and related settlement Proceeds from exercise of common stock warrants Private placement sale of common stock, net of costs Issuance of vested restricted stock units
From September 30, 2017 to September 30, 2018 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Private placement sale of common stock and common stock warrants, net of costs Sale of Series A convertible preferred stock and common stock warrants, net of costs Series A convertible preferred stock dividends and related settlement Conversion of Series A convertible preferred stock into common stock Conversion of Series A convertible preferred stock into Series A-1 convertible preferred stock Series A-1 convertible preferred stock dividends and related settlement Conversion of Series B convertible preferred stock into common stock
From October 1, 2017 to June 30, 2018 Sale of Series A convertible preferred stock and common stock warrants, net of costs Series A convertible preferred stock dividends and settlement Conversion of Series A convertible preferred stock into common stock Conversion of senior secured notes into Series B convertible preferred stock Conversion of Series B convertible preferred stock into common stock Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Private placement sale of common stock and common stock warrants, net of costs
From October 1, 2017 to March 31, 2018 Sale of Series A convertible preferred stock and common stock warrants, net of costs Series A convertible preferred stock dividends and settlement Conversion of senior secured notes into Series B convertible preferred stock Issuance of vested restricted stock units
from October 1, 2017 to December 31, 2017 Sale of Series A convertible preferred stock and common stock warrants, net of costs Conversion of senior secured notes into Series B convertible preferred stock Issuance of vested restricted stock units
From September 30, 2016 To September 30, 2017 Sale of Series A convertible preferred, net of costs Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Issuance of common stock in connection with equity facility Sale of common stock, net of issuance costs
from October 1, 2016 to June 30, 2017 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Issuance of common stock in connection with equity facility Sale of common stock, net of issuance costs
from October 1, 2016 to March 31, 2017 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units Issuance of common stock in connection with equity facility Sale of common stock, net of issuance costs
From October 1, 2016 to December 31, 2016 Proceeds from exercise of common stock warrants Issuance of vested restricted stock units
from October 1, 2015 to June 30, 2016 Reincorporation to a Delaware Corporation Reclassifiation of redeemable common stock upon consummation of the initial public offering Issuance of common stock upon the dissolution of Parilis Conversion of Series A preferred stock in connection with the initial public offering Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs Sale of common stock units upon consummation of initial public offering and concurrent private placement, net of issuance costs On April 26, 2016, the Company filed a certificate of amendment to amend its certificate of incorporation effecting a 1-for-3.45 reverse split of the Company’s common stock.
1.On April 26, 2016, the Company filed a certificate of amendment to amend its certificate of incorporation effecting a 1-for-3.45 reverse split of the Company’s common stock.
from October 1, 2015 to April 27, 2016 Reincorporation to a Delaware Corporation Issuance of preferred and common stock upon the dissolution of Parilis Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs On April 26, 2016, the Company filed a certificate of amendment to amend its certificate of incorporation effecting a 1-for-3.45 reverse split of the Company’s common stock.
from October 1, 2015 to March 31, 2016 Reincorporation to a Delaware Corporation Issuance of common stock upon the dissolution of Parilis Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs
from October 1, 2015 to December 31, 2015 Reincorporation to a Delaware Corporation Issuance of preferred and common stock upon the dissolution of Parilis Employee tax witholdings related to the vesting of restricted stock Sale of common stock, net of issuance costs
from September 30, 2014 to September 30, 2015 Repurchase of Series A redeemable preferred stock and deemed dividends Accretion of redeemable preferred stock, common stock and noncontrolling interests Sale of common stock, net of issuance costs
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。